Haugarvoll K - Search Results

1

Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population.

Balafkan N, Tzoulis C, Müller B, Haugarvoll K, Tysnes OB, Larsen JP, Bindoff LA. Balafkan N, et al. Among authors: haugarvoll k. Mitochondrion. 2012 Nov;12(6):640-3. doi: 10.1016/j.mito.2012.08.004. Epub 2012 Aug 29. Mitochondrion. 2012. PMID: 22963882

2

The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease.

Haugarvoll K, Aarsland D, Wentzel-Larsen T, Larsen JP. Haugarvoll K, et al. Acta Neurol Scand. 2005 Dec;112(6):386-90. doi: 10.1111/j.1600-0404.2005.00389.x. Acta Neurol Scand. 2005. PMID: 16281921

3

LRRK2 and Parkinson's disease in Norway.

Toft M, Haugarvoll K, Ross OA, Farrer MJ, Aasly JO. Toft M, et al. Among authors: haugarvoll k. Acta Neurol Scand Suppl. 2007;187:72-5. doi: 10.1111/j.1600-0404.2007.00852.x. Acta Neurol Scand Suppl. 2007. PMID: 17419834

4

The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study.

Vefring H, Haugarvoll K, Tysnes OB, Larsen JP, Kurz MW; Norwegian ParkWest Study group. Vefring H, et al. Among authors: haugarvoll k. Acta Neurol Scand. 2010 Dec;122(6):438-41. doi: 10.1111/j.1600-0404.2010.01362.x. Acta Neurol Scand. 2010. PMID: 20456244

5

Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease.

Skeie GO, Muller B, Haugarvoll K, Larsen JP, Tysnes OB. Skeie GO, et al. Among authors: haugarvoll k. Mov Disord. 2010 Sep 15;25(12):1847-52. doi: 10.1002/mds.23178. Mov Disord. 2010. PMID: 20669310

6

Parkinson disease: associated disorders in the Norwegian population based incident ParkWest study.

Skeie GO, Muller B, Haugarvoll K, Larsen JP, Tysnes OB. Skeie GO, et al. Among authors: haugarvoll k. Parkinsonism Relat Disord. 2013 Jan;19(1):53-5. doi: 10.1016/j.parkreldis.2012.07.003. Epub 2012 Jul 26. Parkinsonism Relat Disord. 2013. PMID: 22841686

7

Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease.

Müller B, Assmus J, Larsen JP, Haugarvoll K, Skeie GO, Tysnes OB; ParkWest study group. Müller B, et al. Among authors: haugarvoll k. Acta Neurol Scand. 2013 Apr;127(4):290-4. doi: 10.1111/ane.12010. Epub 2012 Sep 23. Acta Neurol Scand. 2013. PMID: 22998158

8

Treatment in early Parkinson's disease: the Norwegian ParkWest study.

Tveiten OV, Skeie GO, Haugarvoll K, Müller B, Larsen JP, Tysnes OB. Tveiten OV, et al. Among authors: haugarvoll k. Acta Neurol Scand. 2013 Aug;128(2):107-13. doi: 10.1111/ane.12055. Epub 2012 Nov 29. Acta Neurol Scand. 2013. PMID: 23190324

9

MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing.

Haugarvoll K, Johansson S, Tzoulis C, Haukanes BI, Bredrup C, Neckelmann G, Boman H, Knappskog PM, Bindoff LA. Haugarvoll K, et al. Orphanet J Rare Dis. 2013 Jan 3;8:1. doi: 10.1186/1750-1172-8-1. Orphanet J Rare Dis. 2013. PMID: 23286897 Free PMC article.

10

Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.

Tzoulis C, Tran GT, Schwarzlmüller T, Specht K, Haugarvoll K, Balafkan N, Lilleng PK, Miletic H, Biermann M, Bindoff LA. Tzoulis C, et al. Among authors: haugarvoll k. Brain. 2013 Aug;136(Pt 8):2393-404. doi: 10.1093/brain/awt103. Epub 2013 Apr 26. Brain. 2013. PMID: 23625061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page